Somatostatin receptor 3

From WikiMD's WELLNESSPEDIA

Somatostatin Receptor 3[edit]

Somatostatin receptor 3 (SSTR3) is a G protein-coupled receptor that binds the peptide hormone somatostatin. It is one of the five known somatostatin receptors, which are involved in a variety of physiological processes including neurotransmission, cell proliferation, and endocrine signaling.

Structure[edit]

SSTR3 is a member of the G protein-coupled receptor (GPCR) superfamily, characterized by seven transmembrane domains. The receptor is encoded by the SSTR3 gene located on chromosome 22 in humans. The structure of SSTR3 allows it to interact with G proteins, which are intracellular proteins that mediate signal transduction from the receptor to various downstream effectors.

Function[edit]

The primary function of SSTR3 is to mediate the effects of somatostatin, a hormone that inhibits the release of several other hormones such as growth hormone, insulin, and glucagon. SSTR3 is involved in the regulation of neuroendocrine and exocrine secretions, as well as in the modulation of neurotransmitter release in the central nervous system.

Expression[edit]

SSTR3 is expressed in various tissues throughout the body, including the brain, pancreas, and gastrointestinal tract. Its expression pattern suggests a role in both central and peripheral physiological processes.

Clinical Significance[edit]

Alterations in SSTR3 expression or function have been implicated in several diseases, including neuroendocrine tumors, Alzheimer's disease, and diabetes mellitus. SSTR3 is a potential target for therapeutic agents designed to modulate somatostatin signaling in these conditions.

Research[edit]

Ongoing research is focused on understanding the precise role of SSTR3 in health and disease, as well as developing selective agonists and antagonists that can modulate its activity. Such compounds could have therapeutic potential in treating disorders associated with dysregulated somatostatin signaling.

See Also[edit]

References[edit]


External Links[edit]

  • Somatostatin Receptor 3 on WikiMD
Stub icon

This article about a biochemical receptor is a stub. You can help WikiMD by expanding the page.

Template:GPCR

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Somatostatin_receptor_3&oldid=6619161"